| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015168164 |
| P356 | DOI | 10.1038/NRCLINONC.2009.18 |
| P698 | PubMed publication ID | 19333226 |
| P5875 | ResearchGate publication ID | 24245504 |
| P50 | author | Mark Emberton | Q63968187 |
| P2093 | author name string | Alex Freeman | |
| Clare Allen | |||
| Hashim U Ahmed | |||
| Manit Arya | |||
| Alex Kirkham | |||
| Rowland Illing | |||
| P2860 | cites work | Cancer statistics, 2006 | Q29615133 |
| Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy | Q30886781 | ||
| Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy | Q30983669 | ||
| Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change | Q34167481 | ||
| Radical prostatectomy versus watchful waiting in early prostate cancer | Q34418166 | ||
| The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants | Q34604597 | ||
| Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis | Q34796351 | ||
| Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? | Q35598144 | ||
| Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant? | Q36018610 | ||
| Complications of transrectal versus transperineal prostate biopsy | Q36058996 | ||
| 20-year outcomes following conservative management of clinically localized prostate cancer | Q36115855 | ||
| Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers | Q36176882 | ||
| MR-guided interventions for prostate cancer | Q36220605 | ||
| Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers | Q36294626 | ||
| The changing face of prostate cancer | Q36309672 | ||
| Active surveillance for prostate cancer: for whom? | Q36309679 | ||
| MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer | Q36321659 | ||
| Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms | Q36339473 | ||
| Comparative accuracy: assessing new tests against existing diagnostic pathways | Q36468809 | ||
| Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy | Q36507722 | ||
| Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature | Q36526052 | ||
| How good is MRI at detecting and characterising cancer within the prostate? | Q36536899 | ||
| Imaging prostate cancer: a multidisciplinary perspective | Q36773229 | ||
| Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning | Q36904024 | ||
| MR imaging in local staging of prostate cancer | Q36906406 | ||
| Will focal therapy become a standard of care for men with localized prostate cancer? | Q36983662 | ||
| Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy | Q37052521 | ||
| Psychological benefits of prostate cancer screening: the role of reassurance | Q37331455 | ||
| Optimization of prostate carcinoma staging: comparison of imaging and clinical methods | Q39371714 | ||
| Why do men refuse or attend population-based screening for prostate cancer? | Q39552052 | ||
| Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging | Q39614126 | ||
| The value of endorectal MRI in the early diagnosis of prostate cancer | Q39655615 | ||
| Early outcomes of active surveillance for localized prostate cancer | Q39713992 | ||
| Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience | Q39727835 | ||
| Measurement of prostate rotation during insertion of needles for brachytherapy | Q40372576 | ||
| Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy | Q40381262 | ||
| Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer | Q40751562 | ||
| Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up | Q40947941 | ||
| Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology | Q41747212 | ||
| Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens | Q43864003 | ||
Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA | Q44459610 | | ||
| Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer | Q44990245 | ||
| Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy | Q45269090 | ||
| Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. | Q46028236 | ||
| High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases | Q46182115 | ||
| Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy | Q46253220 | ||
| Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. | Q46477333 | ||
| Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database | Q46649250 | ||
| Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread | Q46649617 | ||
| Evidence for a biopsy derived grade artifact among larger prostate glands | Q46890165 | ||
| Is tumor volume an independent prognostic factor in clinically localized prostate cancer? | Q47213423 | ||
| Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. | Q51414670 | ||
| Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. | Q51940675 | ||
| Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. | Q52865420 | ||
| Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. | Q52957096 | ||
| Diffusion-weighted imaging of prostate cancer. | Q52974810 | ||
| Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. | Q53599399 | ||
| Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy? | Q53599401 | ||
| Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. | Q53665271 | ||
| Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. | Q53864503 | ||
| Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging. | Q54257303 | ||
| Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. | Q55041226 | ||
| The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis | Q57392760 | ||
| Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate | Q57745049 | ||
| Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study | Q59830949 | ||
| Definition of the prostate in CT and MRI: a multi-observer study | Q61923355 | ||
| Registering histological and MR images of prostate for image-based cancer detection | Q62490562 | ||
| The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy | Q63534288 | ||
| MAGNETIC RESONANCE IMAGING OF CLINICALLY LOCALIZED PROSTATIC CANCER | Q63965984 | ||
| Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings | Q63966248 | ||
| Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? | Q63966486 | ||
| The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy | Q63966719 | ||
| Nonpalpable prostate cancer: detection with MR imaging | Q68182546 | ||
| Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? | Q68896189 | ||
| Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology | Q71024292 | ||
| Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer | Q71132137 | ||
| Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy | Q71657175 | ||
| Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications | Q71975828 | ||
| Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma | Q72631806 | ||
| Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging | Q73271031 | ||
| Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results | Q73383134 | ||
| Magnetic resonance imaging of prostatic cancer: does detection vary between high and low gleason score tumors? | Q73567561 | ||
| Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? | Q74591846 | ||
| Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging | Q74628789 | ||
| Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment | Q76338379 | ||
| Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging | Q78289064 | ||
| Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging | Q79398017 | ||
| Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate | Q79552485 | ||
| Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules | Q79782306 | ||
| Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 | Q80072940 | ||
| Combined MRI and MR spectroscopy of the prostate before radical prostatectomy | Q80159422 | ||
| After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer | Q80442086 | ||
| Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer | Q80609479 | ||
| Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology | Q83970792 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| biopsy | Q179991 | ||
| P304 | page(s) | 197-206 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Nature Reviews Clinical Oncology | Q641640 |
| P1476 | title | Is it time to consider a role for MRI before prostate biopsy? | |
| P478 | volume | 6 |
| Q88503052 | A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI) |
| Q37981828 | A biomedical engineering approach to mitigate the errors of prostate biopsy |
| Q33890165 | A critical comparison of techniques for MRI-targeted biopsy of the prostate |
| Q37876681 | A decade in prostate cancer: from NMR to metabolomics |
| Q47833550 | A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy |
| Q38190115 | A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. |
| Q39564226 | A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer. |
| Q38855337 | Accuracy of high b-value diffusion-weighted MRI for prostate cancer detection: a meta-analysis. |
| Q83254417 | Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy |
| Q30459679 | Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration. |
| Q57518140 | Automated Prostate Gland Segmentation Based on an Unsupervised Fuzzy C-Means Clustering Technique Using Multispectral T1w and T2w MR Imaging |
| Q27316450 | Autonomous real-time interventional scan plane control with a 3-D shape-sensing needle |
| Q37787087 | Benchmarks for success in focal therapy of prostate cancer: cure or control? |
| Q24608010 | Clinical application of a 3D ultrasound-guided prostate biopsy system |
| Q34761435 | Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway |
| Q37610819 | Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies. |
| Q37600905 | Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer |
| Q33611513 | Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy |
| Q35955315 | Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study |
| Q34061419 | Defining the level of evidence for technology adoption in the localized prostate cancer pathway |
| Q47955825 | Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI. |
| Q38874202 | Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. |
| Q42625443 | Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™). |
| Q38910009 | Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI. |
| Q40362614 | Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study |
| Q57317457 | Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging |
| Q53117487 | Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy. |
| Q34463984 | Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? |
| Q24620926 | ESUR prostate MR guidelines 2012 |
| Q43617978 | Editorial comment from Dr Simmons to prostate HistoScanning: a screening tool for prostate cancer? |
| Q44248079 | Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla |
| Q37768170 | Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer |
| Q34448994 | Focal prostate cancer therapy: capabilities, limitations and prospects |
| Q64231463 | Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer |
| Q94082816 | Improving the Diagnosis of Clinically Significant Prostate Cancer with Magnetic Resonance Imaging |
| Q36938017 | Increased rate of positive biopsies using a combination of MR-Tomography, spectroscopy and diffusion-weighted magnetic resonance imaging prior to prostate biopsies in patients with persistent elevated prostate-specific antigen values: A retrospectiv |
| Q43529342 | Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study |
| Q36449937 | Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy |
| Q37690305 | Is focal therapy the future for prostate cancer? |
| Q63966470 | Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI? |
| Q42119774 | Limitations of a contemporary prostate biopsy: The blind march forward |
| Q37254919 | Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer |
| Q53341367 | MR imaging-guided prostate biopsy: technical features and preliminary results. |
| Q38943188 | MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer |
| Q83932123 | MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy |
| Q35068260 | MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men. |
| Q90497407 | Magnetic Nanoparticles in Cancer Therapy and Diagnosis |
| Q39786997 | Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland |
| Q40133335 | Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination |
| Q39446420 | Multi-parametric MRI imaging of the prostate-implications for focal therapy |
| Q38294506 | Multiparametric MRI-targeted TRUS prostate biopsies using visual registration |
| Q26801576 | Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists |
| Q43892603 | Novel technique for MR elastography of the prostate using a modified standard endorectal coil as actuator |
| Q92640606 | Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: Potential role in the diagnosis and management of prostate cancer |
| Q52673993 | Obesity was an independent risk factor for febrile infection after prostate biopsy: A 10-year single center study in South China. |
| Q64912571 | Optimal biopsy strategy for prostate cancer detection by performing a Bayesian network meta-analysis of randomized controlled trials. |
| Q38558548 | PI-RADS version 2: what you need to know |
| Q35700730 | PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer |
| Q37638550 | Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. |
| Q50332464 | Postediting prostate magnetic resonance imaging segmentation consistency and operator time using manual and computer-assisted segmentation: multiobserver study. |
| Q43636204 | Potential of PET/MRI for diagnosis of prostate cancer |
| Q39600655 | Potential of quantitative susceptibility mapping for detection of prostatic calcifications. |
| Q38708189 | Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results. |
| Q37892629 | Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience |
| Q39992577 | Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging |
| Q50906787 | Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model. |
| Q37609671 | Prostate cancer screening and the management of clinically localized disease |
| Q51819245 | Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment. |
| Q50244924 | Prostate focused ultrasound focal therapy--imaging for the future |
| Q39672788 | Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series |
| Q42139974 | RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques |
| Q46509230 | Radical prostatectomy for cT3–4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohort |
| Q46423474 | Rapid quantitative T2 mapping of the prostate using three-dimensional dual echo steady state MRI at 3T. |
| Q42007796 | Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes |
| Q40316580 | Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study |
| Q37975227 | Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer |
| Q31131775 | Review of Prostate Imaging Reporting and Data System version 2. |
| Q38068114 | Risk stratification in prostate cancer screening. |
| Q38109111 | Role of high-field MR in studies of localized prostate cancer |
| Q26998938 | Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer |
| Q39322813 | Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project |
| Q26768765 | Role of multiparametric magnetic resonance imaging in early detection of prostate cancer |
| Q38008282 | Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? |
| Q36140880 | Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2 |
| Q38122089 | TRUS-MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer. |
| Q41214926 | Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results |
| Q35933229 | Targeted prostate biopsy and MR-guided therapy for prostate cancer |
| Q36706373 | Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors |
| Q91935327 | The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors |
| Q36411193 | The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update |
| Q37976257 | The emerging role of diffusion-weighted MRI in prostate cancer management |
| Q38283233 | The optimal timing of post-prostate biopsy magnetic resonance imaging to guide nerve-sparing surgery |
| Q42140991 | The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score |
| Q26849794 | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer |
| Q44682868 | The use of MRI scanning to triage patients |
| Q36928846 | Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer |
| Q49573604 | Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted |
| Q37865154 | Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature |
| Q37813395 | Tumor focality in prostate cancer: implications for focal therapy |
| Q33908505 | Update on prostate imaging |
| Q52960162 | Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization. |
| Q36106249 | Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization |
| Q37964563 | Value of multiparametric MRI in the work-up of prostate cancer |
| Q35985579 | Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer |
| Q46363153 | WITHDRAWN: Endorectal MRI accuracy in auguring tumour location, tumour extent, capsular perforation and seminal vesicle invasion of prostate cancer in north-African men. |
| Q38874201 | What Burden of Prostate Cancer Can Radiologists Rule Out on Multiparametric Magnetic Resonance Imaging? A Sensitivity Analysis Based on Varying the Target Condition in Template Prostate Mapping Biopsies |
| Q49128777 | What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? |
| Q82999261 | [Prostate cancer: the importance of tumor mapping] |
Search more.